T. Ernst

Tolerance to oral H2-receptor antagonists

Clive H. Wilder‐Smith, T. Ernst, M. Gennoni et al. · Digestive Diseases and Sciences · 1990 · 126 citations

Medicine, Pharmacokinetics, Pharmacology +10

Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical Trials

Hugh Taggart, Michael A. Bolognese, Robert Lindsay et al. · Mayo Clinic Proceedings · 2002 · 104 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +5

Loss of acid suppression during dosing with H2-receptor antagonists.

Clive H. Wilder‐Smith, F Halter, T. Ernst et al. · PubMed · 1990 · 75 citations

Medicine, Pharmacology, Pharmacotherapy +16

Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial

Michael Hooper, Peter R. Ebeling, Adam P. Roberts et al. · Climacteric · 2005 · 55 citations

Medicine, Endocrinology, Bone Metabolism +16

Loss of acid suppression during dosing with H₂‐receptor antagonists

Clive H. Wilder‐Smith, F Halter, T. Ernst et al. · Alimentary Pharmacology & Therapeutics · 1990 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +15